Medicamente – program HIV/SIDA, Oncologie, Produse farmaceutice
1 supplier awarded•57 lots awarded•€2.01M awarded
Buyer: Spitalul Judetean de Urgenta Tulcea / Tulcea, Romania
Awarded value
€2.01M
Estimated value
€32.92M
Awarded at 6% of estimated value
Award date
Jun 07, 2026
Winners
1
Lots awarded
57
Award values
Notice total
€2.01M
Sum of lot awards
€31.43M
TED notice total and lot-level values do not exactly match.
Winners
Bucuresti, ROU
€594,433 This contract
820 award notices•2,674 awarded lots•€484.77M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0021 | Framework | Not specified | €5.8M | Antineoplastic agents (33652100) |
| LOT-0018 | Framework | Not specified | €4.5M | Antineoplastic agents (33652100) |
| LOT-0056 | Framework | Not specified | €3.2M | Pharmaceutical products (33600000) |
| LOT-0055 | Framework | Not specified | €3.0M | Pharmaceutical products (33600000) |
| LOT-0019 | Framework | Not specified | €3.0M | Antineoplastic agents (33652100) |
| LOT-0002 | Framework | Not specified | €2.2M | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0048 | Framework | Not specified | €1.8M | Pharmaceutical products (33600000) |
| LOT-0026 | Framework | Not specified | €1.3M | Antineoplastic agents (33652100) |
| LOT-0001 | Framework | Not specified | €1.1M | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0007 | Framework | Not specified | €638,812 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0008 | Framework | ALLIANCE HEALTHCARE ROMANIA | €594,433 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0010 | Framework | Not specified | €567,169 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0024 | Framework | Not specified | €452,375 | Antineoplastic agents (33652100) |
| LOT-0011 | Framework | Not specified | €404,672 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0017 | Framework | Not specified | €397,801 | Antineoplastic agents (33652100) |
| LOT-0040 | Framework | Not specified | €384,095 | Antineoplastic agents (33652100) |
| LOT-0045 | Framework | Not specified | €296,092 | Pharmaceutical products (33600000) |
| LOT-0039 | Framework | Not specified | €292,991 | Antineoplastic agents (33652100) |
| LOT-0025 | Framework | Not specified | €209,771 | Antineoplastic agents (33652100) |
| LOT-0005 | Framework | Not specified | €199,764 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0035 | Framework | Not specified | €133,290 | Antineoplastic agents (33652100) |
| LOT-0004 | Framework | Not specified | €86,078 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0046 | Framework | Not specified | €84,021 | Pharmaceutical products (33600000) |
| LOT-0006 | Framework | Not specified | €76,750 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0030 | Framework | Not specified | €66,508 | Antineoplastic agents (33652100) |
| LOT-0022 | Framework | Not specified | €62,724 | Antineoplastic agents (33652100) |
| LOT-0047 | Framework | Not specified | €58,696 | Pharmaceutical products (33600000) |
| LOT-0049 | Framework | Not specified | €55,465 | Pharmaceutical products (33600000) |
| LOT-0027 | Framework | Not specified | €53,836 | Antineoplastic agents (33652100) |
| LOT-0041 | Framework | Not specified | €47,212 | Antineoplastic agents (33652100) |
| LOT-0003 | Framework | Not specified | €33,540 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0012 | Framework | Not specified | €32,792 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0016 | Framework | Not specified | €30,556 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0050 | Framework | Not specified | €26,770 | Pharmaceutical products (33600000) |
| LOT-0038 | Framework | Not specified | €25,529 | Antineoplastic agents (33652100) |
| LOT-0020 | Framework | Not specified | €25,022 | Antineoplastic agents (33652100) |
| LOT-0009 | Framework | Not specified | €24,235 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0054 | Framework | Not specified | €23,783 | Pharmaceutical products (33600000) |
| LOT-0014 | Framework | Not specified | €23,302 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0044 | Framework | Not specified | €22,591 | Pharmaceutical products (33600000) |
| LOT-0029 | Framework | Not specified | €20,988 | Antineoplastic agents (33652100) |
| LOT-0032 | Framework | Not specified | €20,384 | Antineoplastic agents (33652100) |
| LOT-0028 | Framework | Not specified | €19,941 | Antineoplastic agents (33652100) |
| LOT-0052 | Framework | Not specified | €19,047 | Pharmaceutical products (33600000) |
| LOT-0037 | Framework | Not specified | €17,856 | Antineoplastic agents (33652100) |
| LOT-0023 | Framework | Not specified | €12,044 | Antineoplastic agents (33652100) |
| LOT-0036 | Framework | Not specified | €11,285 | Antineoplastic agents (33652100) |
| LOT-0053 | Framework | Not specified | €11,285 | Pharmaceutical products (33600000) |
| LOT-0033 | Framework | Not specified | €8,450 | Antineoplastic agents (33652100) |
| LOT-0042 | Framework | Not specified | €7,510 | Antineoplastic agents (33652100) |
| LOT-0043 | Framework | Not specified | €6,502 | Pharmaceutical products (33600000) |
| LOT-0031 | Framework | Not specified | €4,993 | Antineoplastic agents (33652100) |
| LOT-0057 | Framework | Not specified | €4,098 | Pharmaceutical products (33600000) |
| LOT-0015 | Framework | Not specified | €2,058 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0034 | Framework | Not specified | €1,086 | Antineoplastic agents (33652100) |
| LOT-0051 | Framework | Not specified | €521 | Pharmaceutical products (33600000) |
| LOT-0013 | Framework | Not specified | €251 | General anti-infectives for systemic use and vaccines (33651000) |